SPF Control
PreclinicalSmall molecule
BayerSPF Control is one of 156 small molecule programs targeting Allergy. It is currently in Preclinical.
5
Indications
17
Total Trials
0
Active Trials
155
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
163 competitors in Acute Lymphoblastic Leukemia
#DrugCompanyPhaseTrials
1Oncovin
Eli LillyPhase 3
Adriamycin
PfizerPhase 3
Wellcovorin
EEastern Cooperative Oncology Group
Phase 3
Oncaspar
SServier
Phase 3
Elspar
DDutch Childhood Oncology Group
Phase 3
Medrol
PfizerPhase 3
Cellcept
RochePhase 3
Neupogen
EEastern Cooperative Oncology Group
Phase 3
Arranon
NovartisPhase 3
Tepadina
Jazz PharmaceuticalsPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
1 more indication
Unspecified12 trials
Show 9 more trials
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for SPF Control. EMBL-EBI & Wellcome Sanger Institute.
- [4]